13F-HR filed by BML Capital Management, LLC
BML Capital Management, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-07, with 25 holding rows worth $160,967,144.
- Accession
- 0001754960-25-000111
- Filer
- CIK 1616824
- Filed
- 2025-02-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 25 entries on the cover page, a total value of $160,967,144 stated on the cover page (in dollars after the unit check, H1), rows summing to $160,967,144 with VALUE read as dollars as filed, 13F file number 028-22948. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 14,250,000 | $35,340,000 | dollars as filed | |
| iShares 0-3 Month Treasury Bond ETF | 46436E718 | SHS | 260,000 | $26,083,200 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 7,608,312 | $25,487,845 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 2,268,064 | $10,591,859 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 5,749,432 | $7,934,216 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 400,000 | $7,636,000 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 4,221,546 | $7,556,567 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 2,100,000 | $6,625,500 | dollars as filed | |
| ORAMED PHARMACEUTICALS INC | 68403P203 | COM NEW | 2,643,907 | $6,398,255 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 3,585,866 | $5,880,820 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,466,684 | $5,234,693 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 4,100,002 | $4,674,002 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 2,093,232 | $2,888,660 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,136,091 | $2,681,175 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 2,775,885 | $1,628,612 | dollars as filed | |
| ASTROTECH CORP | 046484309 | COM | 220,410 | $1,481,155 | dollars as filed | |
| LISATA THERAPEUTICS INC | 128058302 | COM | 284,669 | $848,314 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 42,130 | $505,560 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 150,000 | $442,500 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 48,668 | $327,049 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 9,271 | $267,654 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 273,536 | $210,896 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 174,651 | $122,256 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 184,246 | $77,383 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 20,760 | $42,973 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001754960-25-000111 | this filing | 2025-02-07 | acceptance time not in the bulk data set |